Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors

被引:23
|
作者
Marasini, Bishnu P. [1 ]
Rahim, Fazal [2 ]
Perveen, Shahnaz [3 ]
Karim, Aneela [2 ]
Khan, Khalid Mohammed [2 ]
Atta-ur-Rahman [1 ]
Choudhary, M. Iqbal [1 ,4 ]
机构
[1] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan
[2] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi 75270, Pakistan
[3] Shahrah E Dr Salimuzzaman Siddiqui, PCSIR Labs Complex, Karachi 75280, Pakistan
[4] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 214421, Saudi Arabia
关键词
Benzoxazinone; alpha-Chymotrypsin inhibition; Serine protease; Cytotoxicity; 3T3 cell line; C1R SERINE-PROTEASE; CHRONIC-PANCREATITIS; 4H-3,1-BENZOXAZIN-4-ONES; ENZYME;
D O I
10.1016/j.bioorg.2017.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of benzoxazinones 1-28 were synthesized via reaction of anthranilic acid with various substituted benzoyl chlorides in the presence of triethylamine in chloroform. Compounds 1-18 showed a good inhibition of a-chymotrypsin with IC50 +/- SEM values between 6.5 and 341.1 mu M. Preliminary structure-activity relationships studies indicated that the presence of substituents on benzene ring reduces the inhibitory potential of benzoxazinone. Also the increased inhibitory potential due to fluoro group at phenyl substituent was observed followed by chloro and bromo substituents. Compounds with strong electron donating or withdrawing groups on phenyl substituent, showed a good inhibitory potential at ortho > meta > para position. Kinetics studies showed diverse types of inhibition, except uncompetitive-type inhibition. The Ki values ranged between 4.7 and 341.2 mu M. Interestingly, most of these compounds were non-cytotoxic to 3T3 cell line at 30 mu M, except compounds 6, 14 and 15. Competitive inhibitors of chymotrypsin are like to inhibit other a-chymotrypsin-like serine proteases due to structural and functional similarities between them. The inhibitors identified during the current study deserve to be further studied for their therapeutic potential against abnormalities mediated by chymotrypsin or other serine protease. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:210 / 221
页数:12
相关论文
共 50 条
  • [31] Structure-Activity Relationships of Orotidine-5′-Monophosphate Decarboxylase Inhibitors as Anticancer Agents
    Bello, Angelica M.
    Konforte, Danijela
    Poduch, Ewa
    Furlonger, Caren
    Wei, Lianhu
    Liu, Yan
    Lewis, Melissa
    Pai, Emil F.
    Paige, Christopher J.
    Kotra, Lakshmi P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) : 1648 - 1658
  • [32] Design, synthesis, and quantitative structure-activity relationship of cytotoxic γ-carboline derivatives
    Chen, Jing
    Dong, Xiaowu
    Liu, Tao
    Lou, Jianshu
    Jiang, Chaoyi
    Huang, Wenhai
    He, Qiaojun
    Yang, Bo
    Hua, Yongzhou
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (09) : 3324 - 3331
  • [33] Dihydropyrazole Derivatives Act as Potent α-Amylase Inhibitors and Free Radical Scavengers: Synthesis, Bioactivity Evaluation, Structure-Activity Relationship, ADMET, and Molecular Docking Studies
    Ali, Arif
    Shah, Muhammad Ishaq Ali
    Fu, Chaoping
    Hussain, Zubair
    Qureshi, Muhammad Nasimullah
    Farman, Saira
    Parveen, Zahida
    Zada, Amir
    Nayab, Saira
    Fazil, Perveen
    Ateeq, Muhammad
    Rehman, Gauhar
    Naeem, Mohammad
    Ibrahim, Mohammad
    Khan, Momin
    Khan, Waliullah
    ACS OMEGA, 2023, 8 (23): : 20412 - 20422
  • [34] Synthesis and structure-activity relationship studies of 2,4-thiazolidinediones and analogous heterocycles as inhibitors of dihydrodipicolinate synthase
    Christoff, Rebecca M.
    Soares da Costa, Tatiana P.
    Bayat, Saadi
    Holien, Jessica K.
    Perugini, Matthew A.
    Abbott, Belinda M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 52
  • [35] Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel
    Uoto, K
    Ohsuki, S
    Takenoshita, H
    Ishiyama, T
    Iimura, S
    Hirota, Y
    Mitsui, I
    Terasawa, H
    Soga, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (11) : 1793 - 1804
  • [36] Synthesis of 3-and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities
    Shan, Wei-Guang
    Wang, Han-Guang
    Chen, Yan
    Wu, Rui
    Wen, Yan-Tao
    Zhang, Li-Wen
    Ying, You-Min
    Wang, Jian-Wei
    Zhan, Zha-Jun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3450 - 3453
  • [37] Structure-Activity Relationships of 2-Benzylsulfanylbenzothiazoles: Synthesis and Selective Antimycobacterial Properties
    Klimesova, Vera
    Koci, Jan
    Palat, Karel
    Stolarikova, Jirina
    Dahse, Hans-Martin
    Moellmann, Ute
    MEDICINAL CHEMISTRY, 2012, 8 (02) : 281 - 292
  • [38] Structure-activity relationship studies of 4-methylcoumarin derivatives as anticancer agents
    Miri, Ramin
    Nejati, Maryam
    Saso, Luciano
    Khakdan, Fatemeh
    Parshad, Badri
    Mathur, Divya
    Parmar, Virinder S.
    Bracke, Marc E.
    Prasad, Ashok K.
    Sharma, Sunil K.
    Firuzi, Omidreza
    PHARMACEUTICAL BIOLOGY, 2016, 54 (01) : 105 - 110
  • [39] Structure-activity relationships of synthetic cardiac glycosides
    Takechi, M
    Uno, C
    Tanaka, Y
    PHYTOCHEMISTRY, 1996, 41 (01) : 125 - 127
  • [40] Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization
    Suman, P.
    Murthy, T. Ramalinga
    Rajkumar, K.
    Srikanth, D.
    Dayakar, Ch.
    Kishor, Chandan
    Addlagatta, Anthony
    Kalivendi, Shasi V.
    Raju, B. China
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 90 : 603 - 619